Showing results (121-130 of 6,269) with videos related to

Sort By:
Pageof 627
Diabetes, Obesity & Metabolism|September 8, 2017
β-Cell signalling and insulin secretagogues: A path for improved diabetes therapySusumu Seino, Kenji Sugawara, Norihide Yokoi, et al.
Diabetes, Obesity & Metabolism|September 8, 2017
Exosomes as new players in metabolic organ cross-talkClaudiane Guay, Romano Regazzi
Diabetes, Obesity & Metabolism|September 13, 2017
Insulin resistance and cardiovascular outcomes in the ORIGIN trialHertzel C Gerstein, Ele Ferrannini, Matthew C Riddle, et al.
Diabetes, Obesity & Metabolism|April 24, 2016
Exenatide decreases liver fat content and epicardial adipose tissue in patients with obesity and type 2 diabetes: a prospective randomized clinical trial using magnetic resonance imaging and spectroscopyA Dutour, I Abdesselam, P Ancel, et al.
Diabetes, Obesity & Metabolism|May 11, 2016
A missense variant in GLP1R gene is associated with the glycaemic response to treatment with gliptinsM Javorský, I Gotthardová, L Klimčáková, et al.
Diabetes, Obesity & Metabolism|May 11, 2016
Treatment intensification for patients with type 2 diabetes and poor glycaemic controlA Z Fu, J J Sheehan
Diabetes, Obesity & Metabolism|May 11, 2016
Rates and predictors of hypoglycaemia in 27 585 people from 24 countries with insulin-treated type 1 and type 2 diabetes: the global HAT studyK Khunti, S Alsifri, R Aronson, et al.
Diabetes, Obesity & Metabolism|March 19, 2016
Effect of adding insulin degludec to treatment in patients with type 2 diabetes inadequately controlled with metformin and liraglutide: a double-blind randomized controlled trial (BEGIN: ADD TO GLP-1 Study)V R Aroda, T S Bailey, B Cariou, et al.
Diabetes, Obesity & Metabolism|February 19, 2016
Switching from sulphonylurea to a sodium-glucose cotransporter2 inhibitor in the fasting month of Ramadan is associated with a reduction in hypoglycaemiaW J Wan Seman, N Kori, S Rajoo, et al.
Diabetes, Obesity & Metabolism|December 5, 2015
Acute renal haemodynamic effects of glucagon-like peptide-1 receptor agonist exenatide in healthy overweight menM H A Muskiet, L Tonneijck, M M Smits, et al.
Pageof 627